• Mashup Score: 9

    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and…

    Tweet Tweets with this article
    • Highlights @ASCO #GU23 w/@PGrivasMDPhD - Triple Rx & PARPi #prostatecancer - Adj Nivo & EV/Pembro #Bladder Ca - What’s next in #KidneyCancer? Full Int: - https://t.co/XNS9XsP7Xe - Also on “Oncology Brothers”🎙 @neerajaiims #OncEd #MedTwitter #gusm #oncology @apolo_andrea https://t.co/ktZ9vE1jf4

  • Mashup Score: 5

    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and…

    Tweet Tweets with this article
    • Day 3 #GU23 #KidneyCancer Highlights #CommunityOncology 1. #COSMIC313 Ipi/Nivo/Cabo @tompowles1 2. #CM9ER Nivo/Cabo @DrChoueiri 3. #CaboPoint: Cabo post ICI @AlbigesL 4. Current state https://t.co/s7Ir7TMLMM @ASCO @NazliDizman #GUSM #MedTwitter @montypal @DrYukselUrun

  • Mashup Score: 16

    Your PrivacyASCO is committed to transparency regarding our websites and the ways we process data. When you visit our site, we may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences, your location, or your device and is mostly used to make the site work as you expect it to and to personalize your web experience with…

    Tweet Tweets with this article
    • Day 1 #GU23 #ProstateCacer Highlights #CommunityOncology 1. #TALAPRO2: mCRPC PARPi 1L @neerajaiims  2. #TRITON3: mCRPC PARPi 2L @AlanBryce9  3. #ARASENS update Dara+Doce 1L 4. #PROPEL update PARPi 1L https://t.co/ma9PAah1Jm @ASCO #OncEd #MedEd @OncoAlert #GUSM #MedTwitter

  • Mashup Score: 9

    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and…

    Tweet Tweets with this article
    • With just a week to go for #GU23, @neerajaiims walks us through this Rx algorithm to reiterate the current SoC for #prostatecancer Full Int: - https://t.co/C0gVK1Ue9x - Also on the “Oncology Brothers” podcast #gusm #MedTwitter #OncEd #MedEd #oncology @OncoAlert #onctwitter https://t.co/Ws2CX6AqyG

  • Mashup Score: 1

    The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the awareness and understanding of oncology

    Tweet Tweets with this article
    • 🌎 Today marks #WorldCancerDay2023, and visit our website at https://t.co/ys1d8pDAKO as we continue to update you on the latest in #oncology with exclusive interviews, insightful sessions, and more! #BCsm #LCsm #GUsm #GIsm #PCsm #CRCsm @uicc https://t.co/pNGxKdANUZ

  • Mashup Score: 0

    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and…

    Tweet Tweets with this article
    • To reiterate the SoC for #bladdercancer, @apolo_andrea walks us through this Rx algorithm. To complete the series, #ProstateCancer w/@neerajaiims soon. Full Int: - https://t.co/kfIC9aJzkn - Also on “Oncology Brothers” podcast #gusm #MedTwitter #OncEd #MedEd @OncoAlert https://t.co/sqKLDrRQQr

  • Mashup Score: 7

    The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the awareness and understanding of oncology

    Tweet Tweets with this article
    • We had the opportunity to talk to @AndreaNecchi (@MyUniSR) at #ESMO22 on the latest results from the CheckMate 274 trial of nivolumab in #UrothelialCarcinoma 💊 Keep an eye out on https://t.co/ys1d8pDAKO to see exclusive interviews with leading experts! #UroOnc #GUsm @myESMO https://t.co/htnmunrinm